The Oncosearch | Oncotarget

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

James L. Figarola, Jyotsana Singhal, Sharad Singhal, Jyotirmoy Kusari, Arthur Riggs

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 36945-36965

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer Research Paper

Satoshi Tamada, Taro Iguchi, Minoru Kato, Jumpei Asakawa, Kazuaki Kita, Sayaka Yasuda, Takeshi Yamasaki, Yudai Matsuoka, Kazuyuki Yamaguchi, Kentaro Matsumura, Ishun Go, Tetsuji Ohmachi, Tatsuya Nakatani

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 36966-36974

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Steve Swenson, Catalina Silva-Hirschberg, Weijun Wang, Anupam Singh, Florence M. Hofman, Kristen L. Chen, Axel H. SchÃ¶nthal, Thomas C. Chen

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 37026-37041

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Yves Pommier, Mark Cushman, James H. Doroshow

Published Dec 8, 2018 · Vol. 9, No. 99 · pp. 37286-37288

Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC) Research Perspective

Natalay Kouprina, Yves Pommier, Vladimir Larionov

Published Dec 7, 2018 · Vol. 9, No. 96 · pp. 36833-36835

POU4F2/Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells Research Paper

Lauren J. Maskell, Anupam V. Mahadeo, Vishwanie S. Budhram-Mahadeo

Published Dec 4, 2018 · Vol. 9, No. 95 · pp. 36770-36779

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI Research Paper

Hai-Lun Li, Zhuan Yan, Zun-Ping Ke, Xiao-Feng Tian, Li-Li Zhong, Yong-Tao Lin, Yong Xu, Dong-Hui Zheng

Published Nov 27, 2018 · Vol. 9, No. 93 · pp. 36551-36560

Tumour treating fields in a combinational therapeutic approach Review

Joshua Branter, Surajit Basu, Stuart Smith

Published Nov 27, 2018 · Vol. 9, No. 93 · pp. 36631-36644

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Kazuyoshi Yanagihara, Takanori Kubo, Keichiro Mihara, Takeshi Kuwata, Atsushi Ochiai, Toshio Seyama, Hiroshi Yokozaki

Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36503-36514

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer Research Paper

Giovanny RodrÃguez-Blanco, Lona Zeneyedpour, Diederick Duijvesz, A. Marije Hoogland, Esther I. Verhoef, Charlotte F. Kweldam, Peter C. Burgers, Peter Sillevis Smitt, Chris H. Bangma, Guido Jenster, Geert J.L.H. van Leenders, Lennard J.M. Dekker, Theo M. Luider

Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36444-36456

Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast Research Paper

Maximilian Marhold, Erwin Tomasich, Michael Schwarz, Simon Udovica, Andreas Heinzel, Paul Mayer, Peter Horak, Paul Perco, Michael Krainer

Published Nov 20, 2018 · Vol. 9, No. 91 · pp. 36379-36391

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Piers Blombery, Ella Thompson, Georgina L. Ryland, Rachel Joyce, David J. Byrne, Christine Khoo, Stephen Lade, Mark Hertzberg, Greg Hapgood, Paula Marlton, Anand Deva, Geoffrey Lindeman, Stephen Fox, David Westerman, Miles Prince

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36126-36136

Exosomes impact survival to radiation exposure in cell line models of nervous system cancer Research Paper

Oliver D. Mrowczynski, Achuthamangalam B. Madhankumar, Jeffrey M. Sundstrom, Yuanjun Zhao, Yuka Imamura Kawasawa, Becky Slagle-Webb, Christine Mau, Russell A. Payne, Elias B. Rizk, Brad E. Zacharia, James R. Connor

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36083-36101

Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR) Research Paper

Mario Menschikowski, Carsten Jandeck, Markus Friedemann, Brit Nacke, Saskia Hantsche, Oliver Tiebel, Olga Sukocheva, Albert Hagelgans

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36137-36150

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension Research Paper

Frank Erhard Uschner, Florian Schueller, Ivelina Nikolova, Sabine Klein, Robert Schierwagen, Fernando Magdaleno, Stefanie GrÃ¶schl, Sven Loosen, Thomas Ritz, Christoph Roderburg, Michael Vucur, Glen Kristiansen, Twan Lammers, Tom Luedde, Jonel Trebicka

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36220-36237

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma Research Paper

Shariful Islam, Andrew L. Paek, Michael Hammer, Savithri Rangarajan, Robert Ruijtenbeek, Laurence Cooke, Eric Weterings, Daruka Mahadevan

Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35875-35890

NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma Research Paper

Shugo Ueda, Yoshihiro Miyahara, Yasuhiro Nagata, Eiichi Sato, Taizo Shiraishi, Naozumi Harada, Hiroaki Ikeda, Hiroshi Shiku, Shinichi Kageyama

Published Nov 13, 2018 · Vol. 9, No. 89 · pp. 35997-36011

Correction: Molecular response prediction in CML: novel ideas? Correction

Dominik Wolf, Sieghart Sopper

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35871-35871

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

Darren S. Sigal, Munveer S. Bhangoo, Jonathan A. Hermel, Dean C. Pavlick, Garrett Frampton, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35809-35812

MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs Research Paper

Keiji Okamoto, Tomokazu Ohishi, Mika Kuroiwa, Shun-ichiro Iemura, Tohru Natsume, Hiroyuki Seimiya

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35844-35855

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer Research Paper

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC) Research Perspective

POU4F2/Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells Research Paper

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI Research Paper

Tumour treating fields in a combinational therapeutic approach Review

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer Research Paper

Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast Research Paper

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Exosomes impact survival to radiation exposure in cell line models of nervous system cancer Research Paper

Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR) Research Paper

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension Research Paper

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma Research Paper

NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma Research Paper

Correction: Molecular response prediction in CML: novel ideas? Correction

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer Research Paper

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC) Research Perspective

POU4F2/Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells Research Paper

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI Research Paper

Tumour treating fields in a combinational therapeutic approach Review

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer Research Paper

Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast Research Paper

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Exosomes impact survival to radiation exposure in cell line models of nervous system cancer Research Paper

Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR) Research Paper

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension Research Paper

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma Research Paper

NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma Research Paper

Correction: Molecular response prediction in CML: novel ideas? Correction

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs Research Paper